Based on these results, in March 2024, the FDA approved a new indication for Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight
Successful strategies for maintaining weight loss after stopping tirzepatide include following a low-calorie diet, increasing exercise intensity and duration, and weight tracking
How long does it take to see weight loss results from semaglutide
That potential benefit depends on the final policy and its implementation
Orders are packaged carefully and processed efficiently to help maintain product quality during shipment
Carrillo, Alzheimers Association chief science officer and medical affairs lead, in a statement to Gizmodo